Navigation Links
Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer
Date:2/25/2010

Kinex is a Buffalo, NY based, privately held biopharmaceutical company committed to the discovery and development of novel therapeutics. The Company's platform technologies, Mimetica™ and Opal™, provide unique insight into the design and synthesis of target-based small molecule inhibitors that selectively act on proteins that play key roles in cancer and immuno-inflammatory diseases.

KX2-391 is currently being studied in a Phase 2 clinical trial in prostate cancer patients; additional Phase 2 oncology studies will commence later in 2010. KX2-361 is being developed for brain cancer; an IND is expected during the 4th quarter of 2010. In addition, Kinex is developing several other new product candidates that inhibit key immuno-inflammatory pathways.

For more information, visit www.kinexpharma.com

SOURCE Kinex Pharmaceuticals

Back to top

RELATED LINKS

SOURCE Kinex Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting
2. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results
3. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
4. Jazz Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 3, 2010
5. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
6. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
7. Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains
8. Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks
9. Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
10. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
11. Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  Today, the National Mobility ... the 2015 National Mobility Awareness Month Local Heroes Contest ... Hero online entries that received 1.3 million votes. The ... , Toyota Mobility , and Valley Honda ... and Vantage Mobility International (VMI) and ...
(Date:6/30/2015)... 2015  Avanir Pharmaceuticals, Inc. today announced top-line ... treatment with NUEDEXTA ® was associated with ... affect (PBA) in patients with traumatic brain injury ... characterized by sudden and uncontrollable outbursts of laughing ... brain injury. PRISM II is a phase IV ...
(Date:6/30/2015)... June 30, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... public offering  of 40,229,886 units. Each unit consists of ... A warrant to purchase one share of common stock, ... one share of common stock, at a purchase price ...
Breaking Medicine Technology:NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
... BROOMFIELD, Colo., April 12, 2011 Lanx ® , ... developing and commercializing innovative devices for spinal surgery, today ... (Concero) at the 2011 American Association of Neurological Surgeons ... Concero system is a minimally invasive fixation alternative to ...
... Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY), ... implant therapy to treat diabetes, today announced that it ... through a placement of shares to Otsuka Pharmaceutical Factory, ... Otsuka group of companies. For the placement, Otsuka will ...
Cached Medicine Technology:Lanx®, Inc. Announces Launch of Concero™ Facet Screw System for Spinal Fusion 2LCT and Otsuka of Japan Share Common DIABECELL(R) Vision 2LCT and Otsuka of Japan Share Common DIABECELL(R) Vision 3LCT and Otsuka of Japan Share Common DIABECELL(R) Vision 4LCT and Otsuka of Japan Share Common DIABECELL(R) Vision 5
(Date:6/30/2015)... ... June 30, 2015 , ... Bill Howe Plumbing, ... in San Diego. Bill Howe offers all employees ample opportunity for education and ... most notably through the local Plumbing-Heating-Cooling-Contractors of San Diego (PHCC-SD). The San Diego ...
(Date:6/30/2015)... ... , ... Some may define success as the sum of small efforts repeated ... Athletic Trainers’ Association (NYSATA) and its members continue to be acknowledged and applauded by ... number of members also received honors at the national level. , For ...
(Date:6/30/2015)... ... June 30, 2015 , ... The American Psychiatric ... at Disney’s Coronado Springs Resort in Lake Buena Vista, Florida, and will offer ... premiere event for psychiatric-mental health nursing draws more than 1,500 health care professionals ...
(Date:6/30/2015)... ... June 30, 2015 , ... Medflow, the leader in the ... health records system from the company exclusively dedicated to helping eye care professionals ... intuitive state-of-the-art solution combining modern cloud technology with Medflow’s proven expertise in the ...
(Date:6/30/2015)... ... ... Purdy, the spokesperson for Dephinitive Systems LLC, announces today that the company will officially ... eXtra Operability (XO) which was chosen to reflect the company’s commitment to health care ... XO, based in Cleveland OH, is part of the Cadrillion Capital family of Healthcare ...
Breaking Medicine News(10 mins):Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2Health News:Dephinitive Systems Is Getting a New Name 2
... Still Feel Targeted By Tobacco Advertising and Find It,Easy ... across Kansas will,rally against tobacco on April 2 as ... annual Kick Butts Day, sponsored by the Campaign,for Tobacco-Free ... a list of local events, go to http://www.kickbuttsday.org/events ...
... Still Feel Targeted By Tobacco Advertising & Find It,Easy ... across Florida,will rally against tobacco on April 2 as ... annual Kick Butts Day, sponsored by the,Campaign for Tobacco-Free ... a list of local events, go to, http://www.kickbuttsday.org/events )., ...
... 27 Marshall Erdman &,Associates (Erdman) was ... Healthcare,s" 2008 Construction & Design Survey. The ... industry; it,examines year-over-year sales, contracted square footage ... and number of architects, engineers,and interior designers., ...
... knowledge and building important international relationships is top ... DendriMed Research Director Dr Raisa Monteiro, when she ... in May. , One of two Australian life ... candidates for the prestigious 2008 Advancing BioBusiness Award, ...
... alliances that,lead to increased sales and are mutually ... selection of compatible partners. Companies,that succeed in alliance ... articulating the rationale behind the effort, and then,choosing ... Practices, LLC,s white paper "Generating Value From Strategic,Alliances ...
... Practice Information Management Software Introduces Comprehensive Patient and Information Tracking ... ... Back-Up, DALLAS, March 27 Eklin Medical Systems, a ... Practice Management software for veterinary care,(VIA(R)), is showcasing VIA,s new Hospital ...
Cached Medicine News:Health News:Kansas Kids 'Kick Butts' on April 2 2Health News:Kansas Kids 'Kick Butts' on April 2 3Health News:Florida Kids 'Kick Butts' on April 2 2Health News:Florida Kids 'Kick Butts' on April 2 3Health News:Florida Kids 'Kick Butts' on April 2 4Health News:'Modern Healthcare' Names Marshall Erdman Nation's Top Design-Build Company 2Health News:DendriMed scientist seeks to fast-track success 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 3
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... Coagulation tubes contain a buffered ... available with a citrate concentration ... 0.129 mol/l (3.8%). The mixing ... solution to 9 parts blood. ...
... are available in two versions. ... a clotting activator and is ... serum is required for testing ... is suitable where the testing ...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: